Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
Clinical trial NCT03006302 · COMPLETED
Trial details
- NCT number
- NCT03006302
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2023-08-22
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.